CapsoVision (NASDAQ:CV) Shares Gap Up – Here’s What Happened

Shares of CapsoVision, Inc. (NASDAQ:CVGet Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $11.58, but opened at $12.00. CapsoVision shares last traded at $12.52, with a volume of 24,823 shares changing hands.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Zacks Research upgraded shares of CapsoVision to a “hold” rating in a research report on Wednesday, November 5th. Weiss Ratings restated a “sell (e)” rating on shares of CapsoVision in a research note on Monday, December 22nd. Benchmark reiterated a “speculative buy” rating on shares of CapsoVision in a research report on Friday, November 14th. Finally, Roth Capital set a $7.00 target price on CapsoVision in a research note on Tuesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, CapsoVision has a consensus rating of “Moderate Buy” and an average price target of $6.00.

Get Our Latest Stock Analysis on CapsoVision

CapsoVision Price Performance

The business’s 50 day simple moving average is $7.48.

CapsoVision (NASDAQ:CVGet Free Report) last issued its earnings results on Thursday, November 13th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.03). The firm had revenue of $3.54 million for the quarter.

Hedge Funds Weigh In On CapsoVision

An institutional investor recently bought a new position in CapsoVision stock. Citadel Advisors LLC purchased a new position in shares of CapsoVision, Inc. (NASDAQ:CVFree Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 23,735 shares of the company’s stock, valued at approximately $115,000. Citadel Advisors LLC owned 0.05% of CapsoVision as of its most recent SEC filing.

CapsoVision Company Profile

(Get Free Report)

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.

Featured Articles

Receive News & Ratings for CapsoVision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CapsoVision and related companies with MarketBeat.com's FREE daily email newsletter.